Search Weight Loss Topics:

Page 25«..1020..24252627..3040..»

Home » Hgh » Page 25

Off-label use of human growth hormones (HGHs) as an anti-aging therapy has skyrocketed in the past few years, with the industry set to double its market by 2025. However, many endocrinologists are worried because they believe such therapies should be reserved for those with certain deficiencies. Meanwhile, the rest of the population might be risking their health.

Human growth hormone isa peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. Its a tiny protein secreted by the pituitary gland,a pea-sized organ located near your brain, which circulates through the bloodstream where it serves the functions mentioned above.

Scientists have known about this hormone since the 1920s, but it wasnt really employed in therapy until the 1960s mostly because acquiring it was very difficult. The only source was humans, and gathering it from cadavers didnt really seem like an attractive proposition. However, now it is produced synthetically and is easily available.

Research has alsoshown thatproduction rises during childhood, peaks during puberty, and declines from middle age onward. Its still used as a drug for children who suffer from an HGH deficiency (as well as some adults who suffer from this).

AdultswhoareGH-deficient tend to get larger muscles, have more energy, and improved exercise capacity from replacement therapy. They also experience increased stamina, protection from fractures, and a reduced risk of heart disease.

HGH therapy is approved for treating short stature of unknown cause as well as poor growth due to a number of medical causes, including:

There are some significant side effects, though. Up to 30% of patients experience side effects that include fluid retention, joint and muscle pain, carpal tunnel syndrome, and high blood sugar levels.

Patients with real HGH deficiencies can experience significant metabolic and psychological problems. For them, treatment with HGH can lead to important improvements, leading to reduced visceral and trunk fat mass, and increased lean body mass, skeletal muscle mass, and aerobic capacity.

These health outcomes are extremely appealing for older adults, who are exposed to marketing that suggests HGH therapy has rejuvenating properties.

However, endocrinologists caution that older adults face serious risks when doing so.

Growth hormone definitely is lipolytic and causes fat weight loss, and so that is very enticing to an internist managing a 70-year-old individual who has the resources to pay for growth hormone, Shlomo Melmed, professor of medicine at Cedars-Sinai Medical Center in Los Angeles, told Endocrine Today. What they dont know is the literature. A lack of growth hormone is advantageous to aging and is advantageous to protection against cancer and diabetes. These clinicians may, in fact, be negating any potential benefits of the physiologic drop of growth hormone level that occurs during aging.

Although weight gain, increased fat mass, difficulty concentrating and memory impairment are features of HGH deficiency, theyre also manifestations of aging. In other words, these are natural developments, and interfering with HGH therapy might cascade into undesirable side effects.

Most studies do not actually support the concept that GH administration for elderly individuals, who are secreting relatively low GH, can actually improve functional performance, and furthermore, the potential for toxicity is higher among the elderly population. However, an increase in the illegal use of GH for aging has been exponential in the U.S, said Maria Fleseriu, professor of neurological surgery and professor of medicine in the division of endocrinology, diabetes and clinical nutrition in the School of Medicine at Oregon Health & Science University.

Elderly individuals looking to improve their health should instead turn their attention to improving their lifestyles by eating a balanced diet, exercising, and not stressing too hard.

The rest is here:
Growth hormones have their use, but theyre no fountain of youth - ZME Science

Quartermain joins London-based hgh Consulting on 1 May.

A statement from the firm said the new role "will align with his continued interests in driving change and innovation in the profession, ranging from promoting diversity and inclusion to improving standards of design and promoting regeneration".

Roger Hepher, director of hgh Consulting said: Steves strategic guidance and progressive approach will be a real asset to us; and his arrival is perfectly timed as we work with both private and public sector clients to find ways of helping restore the UK economy and society as the immediate Covid-19 crisis recedes.

Quartermain added: With a natural fit between the issues I want to champion and hghs specialist expertise, Imlooking forward to working with the team.

In early April, Quartermain announced he was taking part-time roles as aconsultant with planning law firm Town Legaland asenior associate at public affairs consultancy Cratus Communications.

In an exclusive interview with Planning shortly after leaving the chief planner role, Quartermain said: Planning is a vocation. I may have retired from the civil service, but I havent retired from planning, although the whole point of retiring is to try to get a better balance between work you get paid for, work you might do to give back to the profession and more time to go running and get on my bike.

"So Im not looking for full-time employment, but I am looking to still make a contribution.

Continued here:
Quartermain joins hgh in non-executive role - PlanningResource

DUBLIN, May 1, 2020 /PRNewswire/ -- The "Global Thermal Imaging Market Analysis & Trends - Industry Forcast to 2028" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The Global Thermal Imaging Market is poised to grow strong during the forecast period 2018 to 2028.

Some of the prominent trends that the market is witnessing include rising adoption of thermal imaging in automotive industry, rising r&d investments by companies, governments, capital firms and growing government expenditure on aerospace & defense sector.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2028. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies.

With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.

Report Highlights

Key Topics Covered

1 Market Outline 1.1 Research Methodology 1.2 Market Trends 1.3 Regulatory Factors 1.4 Product Analysis 1.5 End User Analysis 1.6 Strategic Benchmarking 1.7 Opportunity Analysis

2 Executive Summary

3 Market Overview 3.1 Current Trends 3.1.1 Rising Adoption of Thermal Imaging in Automotive Industry3.1.2 Rising R&D Investments by Companies, Governments, and Capital Firms3.1.3 Growing Government Expenditure on Aerospace & Defense Sector3.1.4 Growth Opportunities/Investment Opportunities3.2 Drivers 3.3 Constraints 3.4 Industry Attractiveness

4 Thermal Imaging Market, By Type 4.1 Solution4.2 Services4.3 Hardware

5 Thermal Imaging Market, By Technology5.1 Uncooled5.2 Cooled

6 Thermal Imaging Market, By Wavelength6.1 Short-Wave Infrared (SWIR)6.2 Mid-Wave Infrared (MWIR)6.3 Long-Wave Infrared (LWIR)

7 Thermal Imaging Market, By Network Product7.1 Thermal Scopes & vision goggles7.2 Thermal Modules7.3 Thermal Cameras7.4 Fixed/mounted cores

8 Thermal Imaging Market, By Application8.1 Personal vision systems8.2 Search & rescue8.3 Monitoring and Inspection8.3.1 Structural Health Monitoring8.3.2 Quality Assessment8.3.3 Machine Condition Monitoring8.3.4 HVAC System Inspection8.4 Security and Surveillance8.4.1 Unmanned Aerial Vehicle (UAV)8.4.2 Tracking8.4.3 Perimeter Security8.5 Detection and Measurement8.5.1 Prototype Assessment8.5.2 Level Measurement8.5.3 Gas Detection8.5.4 Fire/Flare Detection8.5.5 Body Temperature Measurement

9 Thermal Imaging Market, By End User9.1 Residential9.2 Oil & Gas9.3 Industrial9.4 Healthcare & Life Sciences9.5 Government9.6 Food & Beverages9.7 Commercial9.8 Automotive9.9 Aerospace & Defense

10 Thermal Imaging Market, By Geography10.1 North America10.1.1 US10.1.2 Canada10.1.3 Mexico10.2 Europe10.2.1 Germany10.2.2 U.K10.2.3 Italy10.2.4 France10.2.5 Spain10.2.6 Rest of Europe10.3 Asia Pacific10.3.1 China10.3.2 Japan10.3.3 India10.3.4 Australia10.3.5 New Zealand10.3.6 Rest of Asia Pacific10.4 Middle East10.4.1 Saudi Arabia10.4.2 UAE10.4.3 Rest of Middle East10.5 Latin America10.5.1 Argentina10.5.2 Brazil10.5.3 Rest of Latin America10.6 Rest of the World (RoW)10.6.1 South Africa10.6.2 Others

11 Key Player Activities 11.1 Acquisitions & Mergers 11.2 Agreements, Partnerships, Collaborations and Joint Ventures11.3 Product Launch & Expansions 11.4 Other Activities

12 Leading Companies 12.1 Zhejiang Ulirvision Technology Co. Ltd.12.2 Zhejiang Dali Technology Co. Ltd.12.3 Xenics 12.4 United Technologies 12.5 Tonbo Imaging 12.6 Thermoteknix Systems Ltd.12.7 Testo SE & Co. KGaA 12.8 Seek Thermal 12.9 Opgal 12.10 Lynred 12.11 Leonardo S.p.A.12.12 L3Harris Technologies, Inc.12.13 Hgh Infrared Systems 12.14 Fluke Corporation 12.15 FLIR Systems, Inc.12.16 COX 12.17 Calumino 12.18 BAE Systems 12.19 Axis Communications AB

For more information about this report visit https://www.researchandmarkets.com/r/i7b806

Story continues

See original here:
Global Thermal Imaging Markets, 2028: Lucrative Application and End-user Insights - Yahoo Finance

Global Infrared Search & Track (IRST) Systems Market 2020 by Company, Regions, Type and Application, Forecast to 2025

This report is an essential reference for who looks for detailed information on Global Infrared Search & Track (IRST) Systems market. The report covers data on Global markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Global major vendors information.

Global Infrared Search & Track (IRST) Systems MarketResearch Reports provides information regarding market trends, competitive landscape, market analysis, cost structure, capacity, revenue, gross profit, business distribution and forecast 2024.

Our new sample is updated which correspond in new report showing impact of COVID-19 on Industry

The key manufacturers covered in this report are Leonardo S.p.A,Safran S.A.,Lockheed Martin Corporation,Thales Group,HGH Systmes Infrarouges SAS,Rheinmetall AG,Hughes Network Systems LLC,Aselsan A.S.,Northrop Grumman Corporation,Tonbo Imaging Private Limited

Request Sample Copy of Report @ https://www.reportsandmarkets.com/sample-request/global-infrared-search-track-irst-systems-market-2020-by-company-regions-type-and-application-forecast-to-2025?utm_source=coleofduty&utm_medium=41

This report also includes the overall and comprehensive study of the Infrared Search & Track (IRST) Systems market with all its aspects influencing the growth of the market. This report is exhaustive quantitative analyses of the Infrared Search & Track (IRST) Systems industry and provides data for making strategies to increase the market growth and effectiveness.

The Global Infrared Search & Track (IRST) Systems market 2020 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Infrared Search & Track (IRST) Systems market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

In addition to this, regional analysis is conducted to identify the leading region and calculate its share in the globalInfrared Search & Track (IRST) Systemsmarket. Various factors positively impacting the growth of the Infrared Search & Track (IRST) Systems market in the leading region are also discussed in the report. The globalInfrared Search & Track (IRST) Systems marketis also segmented on the basis of types, end users, geography and other segments.

The study objectives of this report are:

To study and analyze the global Infrared Search & Track (IRST) Systems consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

To understand the structure of Infrared Search & Track (IRST) Systems market by identifying its various subsegments.

Focuses on the key global Infrared Search & Track (IRST) Systems manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Infrared Search & Track (IRST) Systems with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Infrared Search & Track (IRST) Systems submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Get Attractive Discount up to 10% on Report @ https://www.reportsandmarkets.com/check-discount/global-infrared-search-track-irst-systems-market-2020-by-company-regions-type-and-application-forecast-to-2025?utm_source=coleofduty&utm_medium=41

Reasons to Buy this Report:

Table of Content:

Chapter One Industry Overview of Infrared Search & Track (IRST) Systems

Chapter Two Manufacturing Cost Structure Analysis

Chapter Three Development and Manufacturing Plants Analysis of Infrared Search & Track (IRST) Systems

Chapter Four Key Figures of Major Manufacturers

Chapter Five Infrared Search & Track (IRST) Systems Regional Market Analysis

Chapter Six Infrared Search & Track (IRST) Systems Segment Market Analysis (by Type)

Chapter Seven Infrared Search & Track (IRST) Systems Segment Market Analysis (by Application)

Chapter Eight Infrared Search & Track (IRST) Systems Major Manufacturers Analysis

Chapter Nine Development Trend of Analysis of Infrared Search & Track (IRST) Systems Market

Chapter Ten Marketing Channel

Chapter Eleven Conclusion

About us

Market research is the new buzzword in the market, which helps in understanding the market potential of any product in the market. This helps in understanding the market players and the growth forecast of the products and so the company. This is where market research companies come into the picture. Reports And Markets is not just another company in this domain but is a part of a veteran group called Algoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

[emailprotected]

Ph: +1-352-353-0818 (US)

The rest is here:
Global Infrared Search & Track (IRST) Systems Market to Witness Huge Growth by 2020-2025 Focusing on Leading Players are Leonardo SpA,Safran...

Importance Of Maintaining Normal HGH Levels In Adults

While most individuals may associate the term HGH with the growth of organs and tissues throughout childhood, it is also a vital substance for older adults. As an individual grows in age after they have reached their third decade of life, they experience a natural reduction in the amount of this hormone that is produced by the pituitary gland in the brain. Changes that take place in an individuals body that may be attributed to a natural decrease in human growth hormone secretion may include: Increased quantity of adipose tissue, especially in the abdominal area Reduced hair and or nail growth Decreased levels of energy and stamina Reduced vision Foggy memory Inability to focus Weakened immune system Decreased muscle mass and strength Reduced ability to control blood sugar levels Poor sleep quality Greater risk of osteoporosis developmentMany of these changes related to aging and reduced secretion of growth hormone in older adults are amplified in individuals who are affected by a condition that is referred to as HGH-deficiency.

According tohghtherapydoc.com, Human growth hormone deficiency develops in an individual when their pituitary gland does not produce an adequate amount of growth hormone for their respective life stage. Maintaining normal levels of growth hormone in the years following the third decade of life is crucial to keeping vital organs and tissues healthy and maintaining an optimal quality of life.

HGH is a type of peptide hormone that is produced by an individuals body in order to promote processes of cell reproduction, cell growth, and cell regeneration. When an individuals pituitary gland secretes growth hormone, it is only available in its active form in the bloodstream for several minutes. An organ that is referred to as the liver takes the growth hormone in the bloodstream and synthesizes it into numerous substances that are called growth factors. The quantity of these growth factors experiences a parallel reduction in quantity with the reduction of growth hormone secretion as an individual grows older.Fortunately, HGH can be replaced in the body through the use of human growth hormone therapy or HRT. Treatment with the use of HRT in men is known to: Help tighten loose skin that has lost its elasticity Help treat erectile dysfunction Increase the growth of hair Improve cognitive function Reduced risk of cardiovascular diseaseTreatment with the use of HRT in women is known to: Balance out the ratio of body fat and lean muscle tissue Normalize irregular sleep patterns Increase skin elasticity Promote a strong immune system Increase bone strength, reducing the risk of osteoporosis Reduced risk of cardiovascular diseaseAn increase in the synthesis of a substance that is called collagen is how human growth hormone helps increase an individuals muscle strength and endurance. Growth factors that are produced by this hormone have an ability to increase the speed of bone regeneration in an individual, making them less susceptible to fractures and breaks. HGH helps an individual maintain a proper body fat percentage through speeding up the process of lipid breakdown or lipolysis.

Numerous actors and actresses have utilized HRT to help decrease their unpleasant symptoms that have manifested due to age-related decreases in human growth hormone secretion.Sylvester Stallone, the actor who plays the famous Rocky Balboa, has discussed his use of human growth hormone under the advice and supervision of his physician in several interviews. Sylvester does not feel that it is a magic potion of sorts, but HRT helps with his levels of endurance and reducing the amount of recovery that is required following exercise. Both of which he has claimed to place wear and tear on his body as he grows older.Actress Suzanne Somers began HRT prescribed by her physician when she didnt feel like herself anymore due to the effects of aging. She utilizes it to help protect her body against the diseases of aging, increased quality of life, and increased bone density. She explains that the benefits of HRT correlate with being prescribed the correct amount, and taking excessive amounts can be dangerous.If the symptoms of low growth hormone secretion sound oddly familiar to you as an aging adult, you may be experiencing the beginning stages of human growth hormone deficiency. While the secretion of HGH does decline over time, it should not impair the quality of your everyday life. Reach out to your physician to see if you may be able to benefit from therapy with the use of HRT.

https://www.mayoclinic.org/healthy-lifestyle/healthy-aging/in-depth/growth-hormone/art-20045735https://draxe.com/nutrition/human-growth-hormone/https://www.medscape.org/viewarticle/458624https://www.metro-md.com/why-hollywood-celebrities-use-hgh/https://ventsmagazine.com/2019/08/15/growth-hormone-use-in-hollywood/https://www.hghexpert.com/135/are-top-celebrities-using-hgh/

View post:
HGH And Celebrities: Why Actors Over 50 Resort To HRT - CelebMix

Market Research Bazaar has made a brilliant attempt to elaborately and meticulously analyze the global Human Growth Hormone (hGH) market in its latest report. All of the market forecasts presented in the report are authentic and reliable.

The new report offers a powerful combination of latest, in-depth research studies on the Human Growth Hormone (hGH) market. The authors of the report are highly experienced analysts and possess deep market knowledge.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures): http://marketresearchbazaar.com/requestSample/15579

Major Players Analyzed Under This Report are:

Eli Lilly and CompanyFerring Holding SAGenentechMerck & Co.Novo NordiskPfizerSandoz International GmbHIpsen

Human Growth Hormone (hGH) Players/Suppliers Profiles and Sales Data: Company, Company Basic Information, Manufacturing Base and Competitors, Product Category, Application and Specification with Sales, Revenue, Price and Gross Margin, Main Business/Business Overview.

Table Of Content

Market Overview: Scope & Product Overview, Classification of Human Growth Hormone (hGH) by Product Category (Market Size (Sales), Market Share Comparison by Type (Product Category)), Human Growth Hormone (hGH) Market by Application/End Users (Sales (Volume) and Market Share Comparison by Application), Market by Region (Market Size (Value) Comparison by Region, Status and ProspectHuman Growth Hormone (hGH) Market by Manufacturing Cost Analysis:Key Raw Materials Analysis, Price Trend of Key Raw Materials, Key Suppliers of Raw Materials, Market Concentration Rate of Raw Materials, Proportion of Manufacturing Cost Structure (Raw Materials, Labor Cost), Manufacturing Process Analysis

Key Benefits for Stakeholders

The study provides an in-depth analysis of the Human Growth Hormone (hGH) market size along with the current trends and future estimations to elucidate the imminent investment pockets.Information about key drivers, restraints, and opportunities and their impact analysis on the market size is provided.Porters five forces analysis illustrates the potency of buyers and suppliers operating in the portable gaming industry.The quantitative analysis of the Human Growth Hormone (hGH) industry from 2020 to 2026 is provided to determine the Human Growth Hormone (hGH) market potential.

Human Growth Hormone (hGH) Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during 2020-2026

The research report is broken down into chapters, which are introduced by the executive summary. Its the introductory part of the chapter, which includes details about global market figures, both historical and estimates. The executive summary also provides a brief about the segments and the reasons for the progress or decline during the forecast period. The insightful research report on the Human Growth Hormone (hGH) market includes Porters five forces analysis and SWOT analysis to understand the factors impacting consumer and supplier behavior.

Get Customized Report in your Inbox within 24 hours: http://marketresearchbazaar.com/enquiry/15579

Market Segment Analysis

The research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type Recombinant Human Growth Hormone (rhGH)Human Growth Hormone (rhGH)

Segment by Application Growth Hormone DeficiencyTurner SyndromeIdiopathic Short StaturePrader-Willi SyndromeSmall for Gestational AgeOthers

Human Growth Hormone (hGH) Market: Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.

Human Growth Hormone (hGH) Market: Regional Analysis

The report offers in-depth assessment of the growth and other aspects of the Human Growth Hormone (hGH) market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.

The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2025. These analyses will help the reader to understand the potential worth of investment in a particular region.

Key Strategic Developments:The study also includes the key strategic developments of the Human Growth Hormone (hGH)market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

Key Market Features:The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, market share, CAGR, and gross margin.Analytical Tools: The Human Growth Hormone (hGH) Market report includes the precisely studied and weighed data of the key industry players and their scope in the Human Growth Hormone (hGH) market by means of several analytical tools

Read More Report: http://marketresearchbazaar.com/requestSample/15579

About (Market Research Bazaar):

Market Research Bazaar (MRB)- a part of VRRB Reports LLP is an overall Market Research and consulting organization. We give unparalleled nature of offering to our clients present all around the world crosswise over industry verticals. Market Research Bazaar has aptitude in giving profound jump showcase understanding alongside advertise knowledge to our clients spread across over different endeavours.

Media Contact:

Market Research Bazaar

UK: +442070973908

US: +13156360953

India: +919548234540

Email: [emailprotected]

Website: http://marketresearchbazaar.com/

Blog: http://marketresearchbazaar.com/blogs

See the original post here:
Global Human Growth Hormone (hGH) Market to Witness Astonishing Growth by 2026 - Cole of Duty

Hamilton Health Sciences (HHS) announced Wednesday (April 22) that they are entering a new stage of pandemic preparednessplanning.

In a news release, the health-care provider said that their current COVID-19 capacity exceeds the number of cases that were projected for the area and, as a result, they will cohort patients with the virus into one ward at the HamiltonGeneral.

"Going forward, HHS will continue to maintain the required bed capacity for patients with COVID-19 assigned to us by Ontario Health," the releasesays.

"Assuming current patient volumes, we will cohort all adult, confirmed COVID-19 positive patients at Hamilton General Hospital (HGH) on units 8 West and ICU East/South, with support from the emergencydepartment."

HHS will also be using the second floor of the Regional Rehabilitation Centre adjacent to the General for COVID-19patients.

Exceptions for moving some cases to the new location may be made but HHS said those decisions will be made on a case-by-casebasis.

"Pediatric and maternal health patients will continue to receive care at McMaster Children's Hospital/McMaster University Medical Centre and will be cohorted according to standard practice," the releasesaid.

In the meantime, HHS says that visitor restrictions and screening at all HHS hospitals across the city will remain in place for the 'foreseeablefuture.'

"We recognize and acknowledge that the measures required to contain this virus have had a significant toll on those who rely on our services, and those who provide care," said Dr. Wes Stephen, EVP Clinical Operations and COO for HHS in therelease.

"I would like to acknowledge the ongoing remarkable efforts of our staff and physicians, and the understanding of our patients and families as we continue to manage thispandemic."

The city of Hamilton reports that there are 354 confirmed cases of COVID-19 inHamilton.

Of those, 13 are being treated at HHShospitals.

See the original post:
Hamilton Health Sciences moving COVID-19 patients to one ward - inthehammer.com

The Hawkesbury and District General Hospital (HGH) is inviting all citizens concerned about COVID-19 to be tested at the Hawkesbury Assessment Centre. The province recently published new guidelines regarding testing criteria and is calling for an increase in the number of tested people to help prevent the spread of the virus and to protect vulnerable people and communities.

Do you have symptoms or do you fear having been in contact with an infected person? Just come for a test at the COVID-19 Assessment Centre in Hawkesbury. Prevention is our best line of defence against the spread of the virus. No appointments and no referrals are needed. All you have to do is show up between 9 a.m. and 5 p.m., Monday to Friday, says Dr. Suzanne Filion, Vice-President of Development and Integration at HGH.

The most common symptoms of COVID-19 are fever, cough, or difficulty breathing. Other signs of infection may include new or worsening respiratory symptoms such as a sore throat, runny nose, sneezing, nasal congestion, hoarse voice, or difficulty swallowing.

Sometimes, an infected person may show less common symptoms such as unexplained fatigue, confusion, falls, worsening of a chronic condition, nausea, vomiting, diarrhea, abdominal pain, chills or headaches. So if you or a loved one have any of the symptoms, please come for a test. It is quick and easy, and it can protect you and your family, adds Dr. Julie Maranda, HGH Chief of Staff.

The province recommends that anyone with symptoms or that has been in close contact with a confirmed case be tested. People considered at a higher risk should also be tested, including healthcare workers, long-term care and retirement homes residents, first responders (firefighters, police officers and paramedics) and other caregivers. The recommendation extends to essential services workers in grocery stores, food services, maintenance, transportation and utilities.

The COVID-19 Assessment Centre is located at 750 Laurier Street in Hawkesbury. The centre is managed by HGH in partnership with the Eastern Ontario Health Unit. Business hours are 9 a.m. to 5 p.m. Monday to Friday.

Thanks for stopping by!

During this time when accurate information has never been more vital, we have opened up our e-edition to everyone.

Because we want to help, in any way we can.

Make a donation through the Ontario Community Newspapers Foundation, and the money will be transferred directly to The Review.

PLUS: You will receive a charitable donation receipt AND our eternal thanks.

Stay safe. Stay strong.

Donate Now

Here is the original post:
Increased COVID-19 testing in Hawkesbury - The Review Newspaper

Human Growth Hormone (hGH) Market 2020

This report studies the Human Growth Hormone (hGH) Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Human Growth Hormone (hGH) Market analysis segmented by companies, region, type and applications in the report.

The major players covered in Human Growth Hormone (hGH) Market Eli Lilly and Company, Ferring Holding SA, Genentech, Merck & Co., Novo Nordisk, Pfizer, Sandoz International GmbH, and Ipsen

The final report will add the analysis of the Impact of Covid-19 in this report Human Growth Hormone (hGH) industry.

Get a Free Sample Copy @ https://www.reportsandmarkets.com/sample-request/global-human-growth-hormone-hgh-market-analysis-2020-with-top-companies-production-consumption-price-and-growth-rate?utm_source=jewishlifenews&utm_medium=36

Human Growth Hormone (hGH) Market continues to evolve and expand in terms of the number of companies, products, and applications that illustrates the growth perspectives. The report also covers the list of Product range and Applications with SWOT analysis, CAGR value, further adding the essential business analytics. Human Growth Hormone (hGH) Market research analysis identifies the latest trends and primary factors responsible for market growth enabling the Organizations to flourish with much exposure to the markets.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Research objectives:

To study and analyze the global Human Growth Hormone (hGH) market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2026.

To understand the structure of Human Growth Hormone (hGH) market by identifying its various sub segments.

Focuses on the key global Human Growth Hormone (hGH) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Human Growth Hormone (hGH) with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Human Growth Hormone (hGH) submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

The Human Growth Hormone (hGH) Market research report completely covers the vital statistics of the capacity, production, value, cost/profit, supply/demand import/export, further divided by company and country, and by application/type for best possible updated data representation in the figures, tables, pie chart, and graphs. These data representations provide predictive data regarding the future estimations for convincing market growth. The detailed and comprehensive knowledge about our publishers makes us out of the box in case of market analysis.

Table of Contents: Human Growth Hormone (hGH) Market

Chapter 1: Overview of Human Growth Hormone (hGH) Market

Chapter 2: Global Market Status and Forecast by Regions

Chapter 3: Global Market Status and Forecast by Types

Chapter 4: Global Market Status and Forecast by Downstream Industry

Chapter 5: Market Driving Factor Analysis

Chapter 6: Market Competition Status by Major Manufacturers

Chapter 7: Major Manufacturers Introduction and Market Data

Chapter 8: Upstream and Downstream Market Analysis

Chapter 9: Cost and Gross Margin Analysis

Chapter 10: Marketing Status Analysis

Chapter 11: Market Report Conclusion

Chapter 12: Research Methodology and Reference

Key questions answered in this report

What will the market size be in 2026 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Inquire More about This Report @ https://www.reportsandmarkets.com/enquiry/global-human-growth-hormone-hgh-market-analysis-2020-with-top-companies-production-consumption-price-and-growth-rate?utm_source=jewishlifenews&utm_medium=36

About Us:

Reports and Markets is not just another company in this domain but is a part of a veteran group called Algoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world. The database of the company is updated on a daily basis. Our database contains a variety of industry verticals that include: Food Beverage, Automotive, Chemicals and Energy, IT & Telecom, Consumer, Healthcare, and many more. Each and every report goes through the appropriate research methodology, Checked from the professionals and analysts.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

Read more:
Human Growth Hormone (hGH) Market to Witness Astonishing Growth With Eli Lilly and Company, Ferring Holding SA, Genentech, Merck & Co., Novo...

0 of 13

As we wrap up Steroid Week at B/R, the only question left is the biggest of them all.

Whether they're currently on the ballot or not, which, if any, "tainted" superstars from Major League Baseball's Steroid Era deserve to be in the Hall of Fame?

Those quotation marks are necessary because there are variations in players' links to performance-enhancing drugs. Whereas some have tested positive or admitted using, others have been tied to PEDs only through the testimony of others. There's also a question of whether some even knew what they were using.

Regardless, we recognize that many hold the position that zero players with ties to PEDs should be allowed into Cooperstown. As Joe Morgan relayed in an open letter in 2017, this is the official position of players who are already in the Hall of Fame:"We hope the day never comes when known steroid users are voted into the Hall of Fame. They cheated. Steroid users don't belong here."

However, allow us to begin with a two-part explanation for why we favor a case-by-case approach.

1 of 13

There's no doubting the sincerity of those who believe Cooperstown is no place for juicers.Rather, the issue with that notion is one of naivete.

Per George Mitchell's2007 reporton PEDs in baseball, steroids had infiltrated MLB at least a decade before Mark McGwire and Sammy Sosachased downRoger Maris' single-season home run record in 1998. Heck, one former major leaguer has claimedsteroids were in the game as far back as the 1960s.

If true, baseball's Steroid Era wasn't limited to the late 1990s and early 2000s. That, in turn, lends credence to whispers (see here, here and here) that there are already users in the Hall's halls.

Granted, MLB officially bannedsteroids in 1991. But sans testing procedures, baseball was basically invoking the honor system. Moreover, the original policy reserved lifetime bans only for repeat offenders who failed to respond to treatment and rehabilitation. So for players,it was all reward and basically no risk.

Given how PED usage is seen as more of a nuisance than an unforgivable transgression in other sports, it's also fair to wonderif the Steroid Era would be so reviled in retrospect if no home run records had fallen during it. As for why those records did fall, it likely has as much to do with a juiced ball as juiced players.

Lastly, there's the Bud Selig conundrum. If the commissioner can be in the Hall of Famedespite his failings during the Steroid Era, the same standard should be applied to players who defined the era.

2 of 13

Ah, but does PED usage nonetheless run afoul of the Hall of Fame's insistence that voters consider the "integrity, sportsmanship, [and] character" of players?

Frankly, there is no other answer than yes. Even though the leaguedidn't exactly promoteits steroid policy, players who took PEDs after 1991 can't use the"I didn't know I couldn't do that" excuse.

Even still, there should be a distinction between those who broke the rules between 1991 and 2004 and those who broke them after testing and policing procedures went into effect in 2005.

Before then, there was was no system to cheat. After, anyone who dared to use knew full well what they were risking. The damage would be not only to their own reputation and finances, but also to their teams and, by extension, their teammates.

Further,the Hall of Fame also urges voters to consider players'"record, playing ability...and contributions to the team(s)on which the player played." Because there's no explicit stipulation stating otherwise, there's room for interpretation that credits in these categories can make up for debits in the other categories.

Hence our preference for going on a case-by-case basis. So without further ado, let's begin with the least deserving candidates and make our way to the most deserving candidates.

3 of 13

Before we get on with more complicated cases, let's begin with three simple ones.

Jose Canseco

He literally wrote the book on juicing in baseball, and in retrospect, his whistle-blowing helped change baseball for the better.

Even still, Canseco's own steroid usage isn't even the best reason why he doesn't belong in Cooperstown. Though he achieved some impressive thingsincluding the first-ever 40-40 seasonbetween 1985 and 2001, neither his offensive production (i.e. his 132 OPS+ and 462 HR) nor his overall performance (i.e. his 42.5 WAR) screams "Hall of Famer."

Jason Giambi

In 2004, he admittedusing human growth hormone and other steroids in the early 2000s, which he more or lessapologized for later.

At his best, Giambi won an MVP and averaged a 176 OPS+ and 41 home runs per year between 2000 and 2003. But like with Canseco, his final 139 OPS+, 440 homers and 50.5 WAR would fall short of Cooperstown standards even if he weren't tied to PEDs.

Eric Gagne

Albeit at the end of his career, he admitted to using HGH during a three-year portion of his decade in the major leagues.

Gagne's biggest claims to fame are his National League Cy Young Award from 2003 and his record-setting 84 straight saves from 2003 to 2004. But the standards for Cooperstown-caliber relievers are pretty high, and his 11.7 WARisn't even half of what Bruce Sutter has on the low end.

4 of 13

If Manny Ramirez'sonly positive test for PEDs had occurred during anapparently imperfectsurvey by MLB in 2003, he'd be a candidate for leniency with regard to the Hall of Fame.

Trouble is, it didn't stop there. Ramirez also tested positive and was banned for 50 games in 2009. Two years later, he abruptly retired when he was facing a 100-game suspension after a second positive test.

Otherwise, Ramirez isone of only four right-handed hitters to rack up a .300/.400/.500 batting line over at least 9,000 plate appearances in the majors. He clubbed 555 home runs in the regular season, plus arecord 29 in the postseason. He was also a 12-time All-Star and two-time World Series champion.

But no thanks to his terrible defense, Ramirez doesn't even outrank fellow left fielder Tim Raines with his 69.3 career WAR. And in addition to his multiple failed PED tests, some of the less pleasant aspects of Ramirez's "Manny Being Manny" persona form another strike against his character.

Frankly, it's surprising that Ramirez has even 28.2 percent of the voters' support after four years on the ballot. It's not as if his connections to PEDs are disputable. And because of what happened in 2011, nobody can even argue that he's already served his time.

Our Verdict:Hard no

5 of 13

Based on his numbers and accolades, Alex Rodriguez is an all-time great and a no-brainer for Cooperstown.

In a 22-year career that spanned 1994 and 2016, A-Rod compiled a 140 OPS+, 696 home runs (fourth all-time) and 117.5 WAR (12th all-time). He was a 14-time All-Star, a 10-time Silver Slugger, a two-time Gold Glover and a three-time MVP.

Though Rodriguez collected only one World Series ring, he truly earned it. Without his 1.308 OPS and six home runs throughout the playoffs, the New York Yankees might not have won it all in 2009.

Rodriguez's ties to PEDs, however, are as troubling as they are indisputable. In response to a report of a positive test from 2003, he admitted in 2009 to using steroids between 2001 and 2003. Years later, he was caught up in the Biogenesis scandal and eventually suspended for the entire 2014 season.

One can argue that Rodriguez's achievements outweigh his misdeeds with PEDs, for which he's alreadypaid dearlyand which have clearly changed him for the better. But at the least, said misdeeds are enough to keep him from being an immediate addition to Cooperstown when he gets on the ballot in 2022.

Our Verdict:Hard no

6 of 13

Even though nobody took it seriously at the time, there was an early tipoff that Mark McGwire was using PEDs amid his trek to a then-record 70 home runs in 1998.

Cut to 12 years later in 2010 and McGwire confessed to theAssociated Press that he used steroids not just in '98, but on and off throughout nearly a decade of his 16-year career between 1986 and 2001.

Sans all of this, McGwire would look like a shoo-in for Cooperstown.His 163 OPS+ and 583 home runs put him in a very small group of elite sluggers. By WAR, he's also one of the 12 best first basemen in history. Next come his accolades, which include a Rookie of the Year, 12 All-Star nods and a World Series ring.

There is, however, no separating any of this from McGwire's confession that PEDs were not a bug during his career, but a feature. That leaves very little (if any) room to wonder if he would have achieved his obviously Cooperstown-worthy numbers if he'd juiced only occasionally or not at all.

McGwire is already off the Hall of Fame ballot, having bowed out with 12.3 percent of the vote in 2016. Even four years later, it's hard to fault the voters for that one.

Our Verdict:Hard no

7 of 13

In getting just13.9 percent of the vote in 2020, Sammy Sosa is still receiving McGwire-level support after eight years on the ballot. That makes some sense as his legacy is inextricably tied to McGwire's.

For what it's worth, Sosa still denies having ever used PEDs. And setting aside Jose Canseco's testimony and a vaguely incriminating encounter withSports Illustrated scribe Rick Reillyin 2002, the strongest evidence that Sosa used is a positive testfrom the survey testing in 2003 that was, once again, imperfect.

As far as what Sosadoes have going for him, his 609 home runs make him one of only nine members of the 600 Home Run Club. He hit 292 of those in a five-year span between 1998 and 2002 when he became the only player ever to rack up three seasons of at least 60 home runs.

On either side of those five seasons, however, Sosa was a good but not great player. That's ultimately felt in his overall career numbers, which include a modest 128 OPS+ and 58.6 career WAR. The latter barely ranks in the top 20 among right fielders.

So though Sosa has more plausible deniability than McGwire with regard to PEDs, it's not enough to overcome the disparity between his suspiciously extraordinary prime and his oddly ordinary career.

Our Verdict:Soft no

8 of 13

Rafael Palmeiro first appeared on the ballot in 2011 and was quickly ousted in 2014 when his 4.4 percent of the vote failed to meet the minimum threshold of 5 percent.

Clearly, memories of 2005 were still fresh. Palmeiro was implicated as a juicer by Jose Canseco in February of that year. Hevehemently deniedever using before congress a few weeks later, but whatever benefit of the doubt he had vanished when hetested positive and was suspended in August.

In 2017, Palmeiro opened up about how he was blindsided by his positive testand also about how he produced three negative tests during an arbitration hearing over his positive test. Though he was suspended anyway, such things do give him a degree of plausible deniability in retrospect.

Performance-wise, Palmeiro was rarely great but consistently very good in a 20-year career that spanned 1986 to 2005. He's notably one of only six players with at least 3,000 hits and 500 home runs, and his 71.9 career WAR ranks eighth among first basemen.

Compared to when Palmeiro was on the ballot, tensions about the Steroid Era have eased a bit in recent years. He would almost certainly have more support in this environment, and it would be well deserved.

Our Verdict:Soft yes

9 of 13

Mere days after he was implicated in the Mitchell Report in 2007, Andy Pettitte admitted to using human growth hormone in 2002.

But as he explained, he used HGH for just two days and only because he was trying to heal an elbow injury. Though he admitted it was an "error in judgment," his case points to a fair question as to whether there's a line between performance-enhancing and performance-allowing.

If there's a knock against Pettitte that has nothing to do with PEDs, it's that he was never the best pitcher in baseball during his 18-year career.To wit, he never won a Cy Young Award, and he made only three All-Star teams.

But in his postseason resume alone, Pettitte has a compelling case for entry into Cooperstown. He's the all-time leader for playoff wins and innings, and he won five of the eight World Series in which he played.

And while certainly unspectacular, Pettitte's regular-season body of work isn't entirely free of merit. He racked up a safely above-average 117 ERA+ over 3,316 innings, andhis 60.7 WARranks 12thamong left-handers.

After two seasons on the ballot, Pettitte has only risen to11.3 percentof the vote. He deserves better.

Our Verdict:Soft yes

10 of 13

In 2004, Gary Sheffield admitted to using a steroid known as "the cream" while training with Barry Bonds during the 2001-02 offseason.

But as Tom Verducci ofSports Illustrated recounted in 2014, Sheffield was proactive in being honest about his usage. He claimed that he didn't know what he was using and that he wasn't happy when he found out: "I was mad. I want everybody to be on an even playing field."

More so than PEDs, perhaps the biggest issue with Sheffield's Hall of Fame resume is his historically awful defense. Fielding runs, for example, rates him as the second-worst fielder ever after only Derek Jeter.

Yet Sheffield still boasts more career WAR (60.5) than fellow right fielder Vladimir Guerrero (59.5), who got into the Hall of Fame on his first ballot in 2018. That points to the 22-year veteran's offensive might, as he's one of only 21 players with more than 500 home runs and at least a 140 OPS+.

Because Sheffield was also a nine-time All-Star and a World Series champion, his case for entry into Cooperstown should be strong enough to overcome his relatively sympathetic story with steroids. At the least, he should get a bump on the30.5 percent of the vote he got in his sixth year on the ballot.

Our Verdict:Soft yes

11 of 13

David Ortiz's one and only connection to steroids is afailed test from the 2003 survey that even Commissioner Rob Manfred warned everyone not to take at face value.

"Even if your name was on that list," Manfred told Bob Nightengale of USA Todayin 2016, "its entirely possible that you were not a positive."

Ultimately, "Big Papi" played about 70 percent of his games in the post-2005 era of testing and punishments for PEDs. And he surely wasn't spared, as he told Verducciin 2019: "Let me tell you, there's not one player in baseball, not one player, that has been drug-tested more than David Ortiz. I guarantee you that."

Altogether, Ortiz racked up a 141 OPS+ and 541 home runs throughout his 20-year career. Those are absolutely Hall of Fame-caliber numbers, and they don't even count his .947 OPS and 17 homers in the postseason. He notably hit .455/.576/.795 in three World Series, all of which he won.

Mind you, Ortiz did all this almost entirely as a designated hitter. The recent inductions of Frank Thomas and Edgar Martinez have somewhat eased the Hall's bias against the position, butneither they nor anyone else has ever been as much of a DH as Ortiz. His 2,027 games at the position are by far a record.

But even if he didn't have any other jobs, Ortiz is nonetheless one of the best regular-season and postseason hitters in history. His appearance on the 2022 ballot should be both his first and his last.

Our Verdict:Hard yes

12 of 13

If judged solely by what he did on the mound, Roger Clemens is perhaps the greatest pitcher in history.

In 24 seasons between 1984 and 2007, "The Rocket" put himself in exceedingly special company by racking up a 143 ERA+ over 4,916.2 innings. He also ranks third all-time in strikeouts (4,672) and WAR (138.7).

Among Clemens' individual prizes are 11 All-Star nods, seven Cy Young Awards, an MVP and two World Series rings. He's also known for pitching some of the most dominant games in history, includingtwo 20-strikeout starts and arguably the greatest of all postseason starts.

Clemens' connection to PEDs, meanwhile, is entirely circumstantial.

He was a key figurein the Mitchell Report, yethe never tested positive and he was ultimately acquitted of perjury in 2012 after denyingusing PEDs to a congressional panel in 2008. By 2012, even Jose Canseco was skeptical that Clemens had ever used.

Despite the lack of actual fire, that Clemens has garnered only 61.0 percentsupport after eight years on the ballot shows that many voters believe there's enough smoke to keep him out of Cooperstown. It's not an altogether unfair position, but we ultimately lean the other way.

Our Verdict:Hard yes

Original post:
Which MLB Steroid Users* Deserve to Be in the Baseball Hall of Fame? - Bleacher Report

Page 25«..1020..24252627..3040..»

Home » Hgh » Page 25